Skip to main content
Fig. 3 | Diagnostic Pathology

Fig. 3

From: Consistency of tumor and immune cell programmed cell death ligand-1 expression within and between tumor blocks using the VENTANA SP263 assay

Fig. 3

Correlation in PD-L1 staining between two sections from the same tumor block. Sample size of 200 NSCLC cases. Using the VENTANA PD-L1 (SP263) assay with the VENTANA OptiView DAB IHC detection kit on the automated VENTANA BenchMark ULTRA platform. IC: tumor-infiltrating immune cells; NSCLC: non-small cell lung cancer; PD-L1: programmed cell death ligand-1; TC: tumor cells

Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us